Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026)
Charlotte's Web Holdings (CWBHF) reported Change in Accured Expenses of $793000.0 for Q1 2026, down 8.64% year-over-year from $868000.0 in Q1 2025, and up 123.94% quarter-over-quarter from -$3.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Change in Accured Expenses data on file, last reported at $793000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $793000.0, down 8.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 132.54% YoY), and the FY2025 annual result was -$1.1 million, down 129.24% from the prior year.
- Change in Accured Expenses grew to $793000.0 in Q1 2026 per CWBHF's latest filing, from -$3.3 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $5.0 million in Q4 2024 and troughed at -$3.3 million in Q4 2025.
- A 5-year average of $125.0 and a median of $570000.0 in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 344.32% in 2022, then surged 941.75% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $661000.0 in 2022, then declined by 27.53% to $479000.0 in 2023, then surged by 941.75% to $5.0 million in 2024, then slumped by 166.37% to -$3.3 million in 2025, then jumped by 123.94% to $793000.0 in 2026.
- Business Quant data shows CWBHF's Change in Accured Expenses at $793000.0 in Q1 2026, -$3.3 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,000.00 |
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | -3.31 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 4.99 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | -980,000.00 |
| Sep 30, 2024 | -980,000.00 |
| Jun 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 479,000.00 |
| Dec 31, 2023 | 479,000.00 |